Cargando…
Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice
Castleman's disease is a lymphoproliferative disorder thought to be related to deregulated production of IL-6. We have previously shown that mice lacking the trans-acting factor C/EBP beta, a transcriptional regulator of IL-6 and a mediator of IL-6 intracellular signaling, develop a pathology n...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192807/ https://www.ncbi.nlm.nih.gov/pubmed/8879230 |
Ejemplares similares
-
Epidemiology and treatment patterns of idiopathic multicentric Castleman disease in the era of IL-6–directed therapy
por: Mukherjee, Sudipto, et al.
Publicado: (2022) -
HIV-associated multicentric Castleman's disease
por: Naime, Fauzia de Fátima, et al.
Publicado: (2012) -
Multicentric Castleman disease and the evolution of the concept
por: Zhou, Ting, et al.
Publicado: (2021) -
Multicentric Castleman's disease developing during follow‐up of sarcoidosis
por: Sawata, Tetsuro, et al.
Publicado: (2016) -
Multicentric Castleman's disease: a case report
por: Menezes, Brian F, et al.
Publicado: (2007)